Vaccination of infants in their first year of life with split inactivated measles vaccine incorporated in a diphtheriapertussis-tetanus-polio (inactivated) vaccine (DPTP-M), compared with live measles vaccination.
D000917:Antibody Formation; D004168:Diphtheria Toxoid / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D008431:Maternal-Fetal Exchange; D008458:Measles Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D010567:Pertussis Vaccine / Q000008:administration & dosage; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage; D011247:Pregnancy; D013745:Tetanus Toxoid / Q000008:administration & dosage; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000627:therapeutic use*
D004168:Diphtheria Toxoid; D008458:Measles Vaccine; D010567:Pertussis Vaccine; D011054:Poliovirus Vaccine, Inactivated; D013745:Tetanus Toxoid; D014613:Vaccines, Attenuated